We wanted to make sure you had seen four key studies just into play
- A groundbreaking study in The Lancet found that marijuana use over four years actually made it harder for patients to cope with chronic pain, and did not reduce their use of opioids.
- A study in Frontiers in Psychiatry found that increasing self-exposure to non-medical marijuana was a predictor of greater odds of opioid dependencediagnosis.
- A study in the International Review of Psychiatry found an increased rate of serious mental illness in states that had legalized medical marijuana.
- In JAMA: "(The) associated acute and long-term psychoactive effects on brain function (of marijuana) are...known. Expanding use of cannabis among pregnant and lactating women (as likely will occur with legalization) may lead to increased risk from fetal and child exposures if the teratogenic potential of cannabis remains underappreciated."
Additional Resources on Link Between Marijuana and Opioids
These articles follow other warnings from medical professionals: the recent editorial published in the Journal of the Society for the Study of Addiction, which cautions against drawing policy conclusions from population studies, and the editorial comment from the American Society of Addiction Medicine on February 20, 2018. And don't forget NIDA's rigorous study showing pot users are twice as likely to have abused opioids and have an opioid use disorder than non-marijuana users.
SAM has published a one-pager describing the overwhelming link between marijuana and opioid abuse. While not every marijuana user will go on to use heroin, nearly all heroin users previously abused marijuana. We need smart policies that discourage use, get people back on their feet, and restore people to participate in and contribute to society. States that have legalized marijuana, by contrast, see increased drugged driving, increased arrests of minority youth, and increased emergency room visits. Colorado is experiencing the highest number of drug overdoses in its history. Legalization is a failed experiment.
Sincerely, Dr. Kevin Sabet President, Smart Approaches to Marijuana (SAM)
Affiliated Fellow, Yale University
Cannabidiol is a chemical that occurs in hemp plants and marijuana. It is possible that cannabidiol oil could help to treat the symptoms of menopause. Researchers have looked at other herbal and natural remedies as treatment options but have not yet proved that any of them are consistently effective…At present, there is very little reliable evidence to suggest that CBD oil can treat the symptoms of menopause. Researchers have only just started to understand how the endocannabinoid system works and the role it may play in different health conditions.
KRISTEN NICHOLS, Hemp Industry Daily May 4, 2018
On Thursday, Feb. 1, 2018, the Cosmic Grind Coffee Shop on Church Street in Burlington, Vermont, started offering CBD hemp oil shots in their drinks. But don't worry, CBD is a 'non-psychoactive' extract, not to be confused with THC in marijuana. RYAN MERCER/FREE PRESS
DENVER (AP) — A federal appeals court sided with the Drug Enforcement Administration and upheld its decision that CBD is a Schedule 1 controlled substance — a major setback for the American hemp industry.
The decision, issued Monday by a three-judge panel of the 9th Circuit in San Francisco, means that hemp producers can only sell cannabidiol where it is allowed under state law.
It also means that states that allow CBD — even if they don't allow the sale of high-THC marijuana - are violating federal law, the same as states that allow recreational cannabis.
CBD producers who brought the case vowed to appeal.
"We will be appealing, and we will be funding that appeal," said Michael Brubeck, CEO of Centuria Natural Foods and a plaintiff in the case.
Based in Las Vegas, Centuria grows hemp and produces CBD products for sale in all 50 states. Centuria was joined in its challenge by the Hemp Industries Association.
CBD case history
The case started in 2016, when the DEA issued a "clarifying rule" stating that CBD is an illegal drug, because it is extracted from marijuana flowers.
Hemp producers cried foul, arguing that CBD can also be extracted from legal hemp flowers, and there is no way to tell whether extracted CBD came from marijuana or from hemp.
Brubeck and the HIA argued that the DEA was attempting to add a new substance to the Controlled Substances Act, something it cannot do.
The DEA said the extract rule was simply a clarification of existing law and that it "makes no substantive change to the government's control of any substance."
The agency also scoffed at the suggestion that CBD is being made from anything but flowering parts of the cannabis plant because cannabinoids "are found in the parts of the cannabis plant that fall within the . definition of marijuana, such as the flowering tops, resin and leaves."
The three-judge panel of the 9th Circuit agreed. Their decision means that the DEA was within its authority to clarify CBD as a "marijuana extract."
For complete article
A New Study on Medical Marijuana by Researchers from the University of California–Davis Reveals That Mold, Bacterial and other Toxic Contaminants Were Discovered in Samples from 20 out of 20 Licensed Dispensaries in Northern California.
Researchers at the University of California, Davis have discovered that medical marijuana from 20 dispensaries contain multiple fungal and bacterial contaminants that are highly toxic and can cause serious and sometimes fatal infections among cannabis users. The researchers have warned users that smoking, vaping or inhaling aerosolized marijuana is a real health risk, especially for those with chronic conditions such as lymphoma, AIDS or other conditions requiring immunosuppressing therapies. The findings will be published in the journal Clinical Microbiology and Infection, titled, “A microbiome assessment of medical marijuana.”
Medical Marijuana for Symptom Control and Its Issues
Legalization without proper scientific scrutiny has led to increasing acceptance in many states. A recent Gallup study showed that a majority of Americans now believe that marijuana is generally safe. Of course, when it is obtained legally and supposedly monitored by state health departments for safety, users assume marijuana dispensaries have met certain regulatory standards to protect consumer safety. But this is not true because the purity, quality and safety is not federally regulated.
Moreover, the idea that vaping is safe drug delivery method is a chimera. Inhaling marijuana in any form provides a pathway deep into the lungs where infections are most dangerous and can spread quickly through the blood. The pathogens found in study samples are all dangerous and could lead to serious illness and death.
Why Does This Matter?
The public has been told that marijuana that is legally attained from a licensed dispensary consists of pure, natural, cannabis which can be safely inhaled as a mist to deliver its supposed medicinal benefits. Moreover, the public believes that temperatures reached by smoking marijuana are high enough to kill any fungi or bacteria. This, of course, is untrue and not substantiated by any research. Medical, and now recreational, use of marijuana has been foisted on the public via the ballot box without any scientific due diligence regarding its safety or efficacy. We are now beginning to pay the piper for this ignorant miscalculation.
April 20, 2018
A Food and Drug Administration panel recommended approval of a drug made of cannabidiol on April 19 to treat two types of epilepsy. The FDA is expected to decide in June whether to accept the panel’s 13-0 recommendation to approve Epidiolex, which would would become the first drug made of cannabidiol, a compound in the cannabis plant, to gain approval from the FDA.
While the panel’s unanimous decision is not binding, the action will no doubt heighten public debate about the use of cannabidiol, medical marijuana, medical cannabis and hemp oil. Should cannabidiol, or CBD, or marijuana be legalized for medical purposes? What is the evidence that these products are beneficial? Are these products safe to use?
Those who support the use of marijuana for recreational or medicinal purposes might have found the timing of the panel’s ruling interesting. National Weed Day is April 20.
But weed is not cannabidiol, even though both come from cannabis.
As a professor of pharmacy with a special interest in epilepsy, I find it important that CBD may be a new option for the treatment of epilepsy. This new use has led me to carefully study published literature on CBD and discuss it as an option with patients who have epilepsy. Additionally, I have been involved with the American Epilepsy Society’s ongoing review of CBD as a possible treatment for epilepsy. From this perspective, I believe that CBD may offer benefits for patients with some types of epilepsy and possibly other disorders.
No high, but healing?
The cannabis plant produces hundreds of different compounds, many of which have differing effects in the body. Tetrahydrocannabinol, or THC, is the substance that is most known for its psychoactive effects, or the “high” associated with marijuana.
However, there are many other substances from the cannabis plant that also produce effects in the body. Many of these differ from THC in that they are not psychoactive – and they do not produce a “high.” Cannabidiol, or CBD, is one of those substances.
Compared to THC, CBD works at different receptors in the brain and other parts of the body. In this way, CBD is very different from THC and may offer new mechanisms of treatment. For this reason, CBD has received a great amount of attention as a possible treatment for many different disorders.
However, there are two well-designed, large studies that indicate CBD is effective in two different epilepsy syndromes. In these studies, about 40 percent of patients taking CBD had a significant reduction in specific types of seizures.
Also see THE ONLY REAL CANNABIS BASED MEDICINE – Pharmaceutically Tested, not ‘home spun quackery’!